BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17011243)

  • 21. Cilostazol stimulates revascularisation in response to ischaemia via an eNOS-dependent mechanism.
    Hori A; Shibata R; Morisaki K; Murohara T; Komori K
    Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):62-5. PubMed ID: 21852163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia in mice.
    Park B; Hoffman A; Yang Y; Yan J; Tie G; Bagshahi H; Nowicki PT; Messina LM
    J Vasc Surg; 2010 Jan; 51(1):165-73. PubMed ID: 19879098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a detrimental role of nitric oxide synthesized by endothelial nitric oxide synthase after peripheral nerve injury.
    Sunico CR; Portillo F; González-Forero D; Kasparov S; Moreno-López B
    Neuroscience; 2008 Nov; 157(1):40-51. PubMed ID: 18824216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia.
    Pfosser A; Thalgott M; Büttner K; Brouet A; Feron O; Boekstegers P; Kupatt C
    Cardiovasc Res; 2005 Feb; 65(3):728-36. PubMed ID: 15664400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease.
    Okamoto N; Tanaka A; Jung K; Karasawa K; Orito K; Matsuda A; Amagai Y; Oida K; Ohmori K; Matsuda H
    Cardiovasc Res; 2011 Nov; 92(2):209-17. PubMed ID: 21771896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro pharmacological study of femoral artery vascular reactivity after inferior canine hindlimb ischemia/reperfusion: effects of in vivo nitric oxide blocker infusion.
    Joviliano EE; Piccinato CE; Cherri J; Viaro F; Moryia T; Celotto AC; Bonaventura D; Evora PR
    Ann Vasc Surg; 2007 Sep; 21(5):618-28. PubMed ID: 17823044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sympathetic nervous system regulates bone marrow-derived cell egress through endothelial nitric oxide synthase activation: role in postischemic tissue remodeling.
    Récalde A; Richart A; Guérin C; Cochain C; Zouggari Y; Yin KH; Vilar J; Drouet I; Lévy B; Varoquaux O; Silvestre JS
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):643-53. PubMed ID: 22267478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of nitric oxide dependent and independent vasodilation on impaired hindlimb revascularization in eNOS
    Martínez-Ruiz M; Vargas-Robles H; Rios A; Sánchez D; Escalante B
    Can J Physiol Pharmacol; 2019 May; 97(5):377-385. PubMed ID: 30624957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemia/reperfusion-induced low reactivity of the rat superior mesenteric vascular bed is associated with expression of nitric oxide synthases.
    Chen CF; Leu FJ; Chen HI; Wang D; Chou SJ
    Transplant Proc; 2006 Sep; 38(7):2216-20. PubMed ID: 16980047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Red wine polyphenols prevent acceleration of neovascularization by angiotensin II in the ischemic rat hindlimb.
    Walter A; Etienne-Selloum N; Brasse D; Schleiffer R; Bekaert V; Vanhoutte PM; Beretz A; Schini-Kerth VB
    J Pharmacol Exp Ther; 2009 May; 329(2):699-707. PubMed ID: 19193929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repetitive remote occlusion (RRO) stimulates eNOS-dependent blood flow and collateral expansion in hindlimb ischemia.
    Schuler D; Sansone R; Nicolaus C; Kelm M; Heiss C
    Free Radic Biol Med; 2018 Dec; 129():520-531. PubMed ID: 30336250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time monitoring of nitric oxide and blood flow during ischemia-reperfusion in the rat testis.
    Kono T; Saito M; Kinoshita Y; Satoh I; Shinbori C; Satoh K
    Mol Cell Biochem; 2006 Jun; 286(1-2):139-45. PubMed ID: 16496212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pial microvascular responses to transient bilateral common carotid artery occlusion: effects of hypertonic glycerol.
    Lapi D; Marchiafava PL; Colantuoni A
    J Vasc Res; 2008; 45(2):89-102. PubMed ID: 17934320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of nitric oxide in the post-ischemic revascularization process.
    Luque Contreras D; Vargas Robles H; Romo E; Rios A; Escalante B
    Pharmacol Ther; 2006 Nov; 112(2):553-63. PubMed ID: 16950515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.
    Qian HS; Liu P; Huw LY; Orme A; Halks-Miller M; Hill SM; Jin F; Kretschmer P; Blasko E; Cashion L; Szymanski P; Vergona R; Harkins R; Yu J; Sessa WC; Dole WP; Rubanyi GM; Kauser K
    Gene Ther; 2006 Sep; 13(18):1342-50. PubMed ID: 16642030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise-induced hyperemia unmasks regional blood flow deficit in experimental hindlimb ischemia.
    Brevetti LS; Paek R; Brady SE; Hoffman JI; Sarkar R; Messina LM
    J Surg Res; 2001 Jun; 98(1):21-6. PubMed ID: 11368533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased ischemia-reperfusion blood flow impairs the skeletal muscle contractile function.
    Ikebe K; Kato T; Yamaga M; Hirose J; Tsuchida T; Takagi K
    J Surg Res; 2001 Jul; 99(1):1-6. PubMed ID: 11421597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
    Schgoer W; Theurl M; Jeschke J; Beer AG; Albrecht K; Gander R; Rong S; Vasiljevic D; Egger M; Wolf AM; Frauscher S; Koller B; Tancevski I; Patsch JR; Schratzberger P; Piza-Katzer H; Ritsch A; Bahlmann FH; Fischer-Colbrie R; Wolf D; Kirchmair R
    Circ Res; 2009 Nov; 105(10):994-1002. PubMed ID: 19797703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chronic pre-treatment with angiotensin converting enzyme inhibition on skeletal muscle mitochondrial recovery after ischemia/reperfusion.
    Thaveau F; Zoll J; Bouitbir J; N'guessan B; Plobner P; Chakfe N; Kretz JG; Richard R; Piquard F; Geny B
    Fundam Clin Pharmacol; 2010 Jun; 24(3):333-40. PubMed ID: 19682081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.